We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
-0.63%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$43.7M
(+43%)
Cap. Flow
+$49.2M
Cap. Flow
% of AUM
33.95%
Top 10 Holdings %
Top 10 Hldgs %
24.02%
Holding
223
New
58
Increased
36
Reduced
83
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$6.28M |
| 2 |
Centene
CNC
|
+$3.55M |
| 3 |
Harmony Biosciences
HRMY
|
+$3.07M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
+$2.84M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$2.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aurinia Pharmaceuticals
AUPH
|
+$2.42M |
| 2 |
PennyMac Financial
PFSI
|
+$1.76M |
| 3 |
AirSculpt Technologies
AIRS
|
+$1.33M |
| 4 |
Starwood Property Trust
STWD
|
+$1.19M |
| 5 |
Ametek
AME
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.03% |
| 2 | Real Estate | 10.47% |
| 3 | Financials | 4.37% |
| 4 | Energy | 4.28% |
| 5 | Technology | 3.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cigna
CI
$74.5B
| $320K | 0.22% |
1,251
-36
| -3% | -$10.5K |
|
102
Progressive
PGR
$121B
| $302K | 0.21% |
2,108
-39
| -2% | -$5.38K |
|
103
General Mills
GIS
$20.3B
| $299K | 0.21% |
3,495
-41
| -1% | -$3.27K |
|
104
D.R. Horton
DHI
$42.4B
| $293K | 0.2% |
3,000
| – | – |
|
105
State Street SPDR S&P International Dividend ETF
DWX
$525M
| $291K | 0.2% |
+8,497
| New | +$288K |
|
106
Invesco S&P 500 BuyWrite ETF
PBP
$348M
| $289K | 0.2% |
+13,653
| New | +$285K |
|
107
Hershey
HSY
$34.8B
| $287K | 0.2% |
1,128
-16
| -1% | -$3.76K |
|
108
Nucor
NUE
$53.9B
| $286K | 0.2% |
1,851
-88
| -5% | -$14K |
|
109
Cenovus Energy
CVE
$52.1B
| $284K | 0.2% |
16,258
-802
| -5% | -$14.7K |
|
110
PepsiCo
PEP
$187B
| $268K | 0.18% |
1,469
-27
| -2% | -$4.72K |
|
111
AbbVie
ABBV
$450B
| $268K | 0.18% |
1,679
-14
| -0.8% | -$2.14K |
|
112
Cencora
COR
$59.9B
| $265K | 0.18% |
1,652
-26
| -2% | -$4.13K |
|
113
Imperial Oil
IMO
$59.2B
| $262K | 0.18% |
5,154
-277
| -5% | -$13.8K |
|
114
Republic Services
RSG
$68.4B
| $261K | 0.18% |
1,933
-28
| -1% | -$3.57K |
|
115
McKesson
MCK
$98.5B
| $260K | 0.18% |
731
-12
| -2% | -$4.33K |
|
116
Hewlett Packard
HPE
$60.7B
| $260K | 0.18% |
16,318
-695
| -4% | -$10.9K |
|
117
Globe Life
GL
$14.3B
| $255K | 0.18% |
2,319
-39
| -2% | -$4.58K |
|
|
MRO
118
DELISTED
Marathon Oil Corporation
MRO
| $255K | 0.18% |
10,631
-512
| -5% | -$13.1K |
|
|
PXD
119
DELISTED
Pioneer Natural Resource Co.
PXD
| $255K | 0.18% |
1,247
-65
| -5% | -$14K |
|
120
Genuine Parts
GPC
$17.2B
| $253K | 0.17% |
1,510
-29
| -2% | -$4.89K |
|
121
Aflac
AFL
$63.5B
| $252K | 0.17% |
3,905
-49
| -1% | -$3.35K |
|
122
VanEck High Yield Muni ETF
HYD
$4.49B
| $250K | 0.17% |
+4,840
| New | +$250K |
|
123
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.08B
| $250K | 0.17% |
+10,000
| New | +$250K |
|
124
UnitedHealth
UNH
$387B
| $246K | 0.17% |
520
-10
| -2% | -$4.83K |
|
125
Johnson & Johnson
JNJ
$609B
| $244K | 0.17% |
1,577
-19
| -1% | -$3.07K |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, AlphaCentric Advisors held 223 positions worth $145M, up 43% from $101M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
AlphaCentric Advisors deployed $49.2M of net new capital in Q1 2023, opening 58 new positions and adding to 36 existing holdings. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 76,992 shares worth $6.33M.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 57% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was Aurinia Pharmaceuticals, an estimated $2.42M trimmed.
- AlphaCentric Advisors's largest Q1 2023 buy was iShares 1-3 Year Treasury Bond ETF: 76,992 shares worth $6.33M.
- AlphaCentric Advisors added most to BioCryst Pharmaceuticals in Q1 2023, an estimated $2.84M increase.
- AlphaCentric Advisors's biggest Q1 2023 reduction was Aurinia Pharmaceuticals, cutting an estimated $2.42M.
- AlphaCentric Advisors fully exited PennyMac Financial in Q1 2023, selling an estimated $1.76M.
- AlphaCentric Advisors's ten largest holdings make up 24% of its $145M portfolio in Q1 2023.
- AlphaCentric Advisors opened 58 new positions and closed 14 in Q1 2023.
- AlphaCentric Advisors's portfolio value rose 43% quarter-over-quarter to $145M.
Based on AlphaCentric Advisors's 13F filing for Q1 2023, filed 12 May 2023.